Raquel Sanchez-Valle
Servei de Neurologia NeuròlogaGrup de recerca
- Malaltia d'Alzheimer i altres trastorns cognitius Group leader (R4)
Sobre mi
Neuròloga formada a l’Hospital Clínic de Barcelona (2000) i doctora en Biopatologia per la Universitat de Barcelona (2003). Després d’un contracte Rio Hortega (ISCIII) per a una especialització en neurologia cognitiva que va incloure una estada postdoctoral curta a la UCSF, vaig ser contractada com a especialista en neurologia a l’Hospital Clínic Barcelona (2006). Lidero el Grup d’Alzheimer a la FRCB-IDIBAPS des de 2018 i sóc professora agregada a la UB. Vaig ser cap de neurologia (2018-2023) i, des de gener de 2024, sóc Directora Mèdica del Clínic Barcelona.
Publicacions destacades
-
Design and validation of the 1-week memory battery for assessing episodic memory and accelerated long-term forgetting in cognitively unimpaired subjects
Autors:Referència: NEUROPSYCHOLOGY 2023. -
Classifying Alzheimer's disease and frontotemporal dementia using machine learning with cross-sectional and longitudinal magnetic resonance imaging data
Autors:Referència: HUMAN BRAIN MAPPING 2023. -
The APOE4 effect: Structural brain differences in Alzheimer's disease according to the age at symptom onset
Autors:Referència: EUROPEAN JOURNAL OF NEUROLOGY 2023. -
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study
Autors:Referència: JOURNAL OF NEUROLOGY 2023. -
Diagnostic Performance and Clinical Applicability of Blood-Based Biomarkers in a Prospective Memory Clinic Cohort
Autors:Referència: NEUROLOGY 2023. -
Sex differences in early-onset Alzheimer's disease
Autors:Referència: EUROPEAN JOURNAL OF NEUROLOGY 2022. -
Temporal order of clinical and biomarker changes in familial frontotemporal dementia
Autors:Referència: NATURE MEDICINE 2022. -
CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome
Autors:Referència: Frontiers in Immunology 2022. -
Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias
Autors:Referència: Alzheimers & Dementia 2020.
Projectes destacats
-
Genetic dementias (genetic Alzheimer’s disease, frontotemporal dementia and prion diseases):longitudinal changes and expression and epigenetic differences with sporadic cases.
Investigador/a principal: Raquel Sanchez del Valle DíazFinançador: Instituto de Salud Carlos IIICodi: PI20/ 00448Durada: 01/01/2021 - 30/06/2025 -
Estudio de biomarcadores y desarrollo de nuevas estrategias terapéuticas en una cohorte multicéntrica de Demencia Frontotemporal.
Investigador/a principal: Raquel Sanchez del Valle DíazFinançador: Departament de Salut de la Generalitat de CatalunyaCodi: SLT002/16/00408Durada: 27/03/2017 - 31/12/2023 -
Study of genetic frontotemporal dementia in preclinical and early stages of the disease: cognitive performance, structural and functional neuroimaging and biochemical markers.
Investigador/a principal: Raquel Sanchez del Valle DíazFinançador: Fundació La Marató de TV3Codi: TV3-20143810Durada: 15/05/2015 - 15/11/2021 -
Phase II/III Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Investigador/a principal: Raquel Sanchez del Valle DíazFinançador: National Institute on Aging (NIH)Durada: 14/07/2014 -
Alzheimer’s Disease Prediction Service (ADPS): digital biomarker for Real-World Evidence (RWE) in AD
Investigador/a principal: Raquel Sanchez del Valle DíazFinançador: EIT HealthCodi: EIT Health 18066/2017Durada: 01/01/2018 - 31/12/2018
